Señales en vivo de HBC.OL | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 10:25):

Stats
Volumen de hoy	51 103.00
Volumen promedio	243 280
Capitalización de mercado	849.42M
EPS	Kr.-0.0955 ( 2023-03-31 )
Próxima fecha de ganancias	( Kr.0 ) 2024-05-10
Last Dividend	Kr.0 ( N/A )
Next Dividend	Kr.0 ( N/A )
P/E	-7.96
ATR14	Kr.0.0540 (2.58%)

Hofseth BioCare ASA Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas
SSG.OL	-0.816

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hofseth BioCare ASA Finanzas

Annual	2023
Ingresos:	Kr.190.82M
Beneficio Bruto:	Kr.-54.56M (-28.59 %)
EPS:	Kr.-0.270

FY	2023
Ingresos:	Kr.190.82M
Beneficio Bruto:	Kr.-54.56M (-28.59 %)
EPS:	Kr.-0.270

FY	2022
Ingresos:	Kr.120.45M
Beneficio Bruto:	Kr.28.51M (23.67 %)
EPS:	Kr.-0.370

Financial Reports:

No articles found.

Hofseth BioCare ASA

Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome. The company was founded in 2000 and is headquartered in Ålesund, Norway.

Actualizaciones en tiempo real para Hofseth BioCare ASA [HBC.OL]

Upcoming Earnings Alert